Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Locteron vs PEG-Intron in Chronic Hepatitis C
NCT00593151Phase 2Completed
- Sponsor
- Biolex Therapeutics
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-2b in hepatitis C (HCV), sponsored by Biolex Therapeutics. Started Jan 2008; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00593151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593151.